Skip to content

Median effective dose of esketamine for pediatric patients undergoing day surgery

Median effective dose of esketamine for pediatric patients undergoing day surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042556
Enrollment
Unknown
Registered
2021-01-23
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phimosis, redundant prepuce

Interventions

Experimental group:Esketamine

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: (1) Children 3-7 years old. (2) The expected surgical method was circumcision. (3) The operation was performed under intravenous anesthesia of esketamine. (4) No previous history of systemic disease. (5) Informed consent was obtained from parents or guardians.

Exclusion criteria

Exclusion criteria: (1) ASA grading >= 2. (2) Non-outpatient route surgery or emergency surgery. (3) Abnormal liver function, and history of other systemic diseases. (4) Using of sedatives (e.g., propofol, morphine, fentanyl, midazolam, dexmedetomidine, ketamine) or recent use of any sedatives(withdrawal time < 24 h).

Design outcomes

Primary

MeasureTime frame
dose of esketamine;

Secondary

MeasureTime frame
mean arterial pressure;heart rate;Pulse oxygen saturation;adverse events;

Countries

China

Contacts

Public ContactBo Li

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

2499571132@qq.com+86 13818402827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026